Mayrhofer Michaela Th
Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
Papillon Pathways e.U., Landskron, Austria.
Front Digit Health. 2025 Sep 3;7:1626833. doi: 10.3389/fdgth.2025.1626833. eCollection 2025.
Artificial Intelligence is increasingly shaping the practice of biobanking by influencing how biobanks evolve and operate, especially when it concerns their relationship to data. By assessing four key parameters-size, site, speed, and access-this paper analyzes the impact of AI technologies on biobanks, presenting them as dynamic boundary objects that produce biovalue by transforming biological material and data into intangible assets of the data-driven bioeconomy. Historically rooted at the intersection of health research and healthcare, biobanking is continually reshaped by emerging technologies, policies, and societal expectations. While biobanks were originally defined as collections of samples and associated data, they have recently evolved into complex infrastructures for both data and samples.
人工智能正日益通过影响生物样本库的发展和运营方式来塑造其实践,尤其是在涉及生物样本库与数据的关系时。通过评估四个关键参数——规模、地点、速度和获取——本文分析了人工智能技术对生物样本库的影响,将它们呈现为动态边界对象,这些对象通过将生物材料和数据转化为数据驱动型生物经济的无形资产来产生生物价值。生物样本库起源于健康研究与医疗保健的交叉领域,不断受到新兴技术、政策和社会期望的重塑。虽然生物样本库最初被定义为样本及相关数据的集合,但它们最近已演变成用于数据和样本的复杂基础设施。